Sichuan Huiyu Pharmaceutical Co., Ltd.

SHSE:688553 Voorraadrapport

Marktkapitalisatie: CN¥5.5b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Sichuan Huiyu Pharmaceutical Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Zhao Ding

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO26.9%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Here's Why Sichuan Huiyu Pharmaceutical (SHSE:688553) Can Manage Its Debt Responsibly

Sep 29
Here's Why Sichuan Huiyu Pharmaceutical (SHSE:688553) Can Manage Its Debt Responsibly

Sichuan Huiyu Pharmaceutical (SHSE:688553) Has A Pretty Healthy Balance Sheet

Jun 07
Sichuan Huiyu Pharmaceutical (SHSE:688553) Has A Pretty Healthy Balance Sheet

Sichuan Huiyu Pharmaceutical Co., Ltd.'s (SHSE:688553) 33% Share Price Surge Not Quite Adding Up

Mar 07
Sichuan Huiyu Pharmaceutical Co., Ltd.'s (SHSE:688553) 33% Share Price Surge Not Quite Adding Up

CEO

Zhao Ding (39 yo)

no data

Tenure

CN¥1,458,500

Compensatie

Dr. Zhao Ding is Non- Executive Director of TYK Medicines, Inc from January 17, 2024 and servd as its Director since January 17, 2024 until January 8, 2024. Dr. Ding has experience in the pharmaceutical in...